These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 10164530)

  • 1. Getting ACE inhibitors into the right hands.
    Bilodeau A
    Manag Care; 1997 Jan; 6(1):31-2. PubMed ID: 10164530
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancing quality of heart failure care in managed Medicare and Medicaid in North Carolina: results of the North Carolina Achieving Cardiac Excellence (NC ACE) Project.
    Goff DC; Massing MW; Bertoni AG; Davis J; Ambrosius WT; McArdle J; Duren-Winfield V; Sueta CA; Croft JB
    Am Heart J; 2005 Oct; 150(4):717-24. PubMed ID: 16209973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congestive heart failure management program honored for outcomes, cost savings.
    Levenson D
    Rep Med Guidel Outcomes Res; 2001 Nov; 12(22):6-7. PubMed ID: 12389584
    [No Abstract]   [Full Text] [Related]  

  • 5. Are physicians failing CHF patients?
    Phillips L
    Hosp Technol Ser; 1997 Jun; 16(7):4-5. PubMed ID: 10169072
    [No Abstract]   [Full Text] [Related]  

  • 6. Measuring progress toward practice guidelines.
    Firshein J
    Bus Health; 1996 May; 14(5):38-42. PubMed ID: 10157916
    [No Abstract]   [Full Text] [Related]  

  • 7. Perspectives. Clinical practice guidelines: winning a dubious audience.
    Wingerson L
    Faulkner Grays Med Health; 1995 Mar; 49(12):suppl 1-4. PubMed ID: 10140605
    [No Abstract]   [Full Text] [Related]  

  • 8. Letter regarding article by Masoudi et al, "national patterns of use and effectiveness of angiotensin-converting enzyme inhibitors in older patients with heart failure and left ventricular systolic dysfunction".
    Sabatini T; Rozzini R; Trabucchi M
    Circulation; 2005 May; 111(17):e276-7; author reply e276-7. PubMed ID: 15867189
    [No Abstract]   [Full Text] [Related]  

  • 9. ACE inhibitor/CHF interim report. West Virginia Medical Institute.
    Sobel ER
    Del Med J; 1999 Jan; 71(1):19-20. PubMed ID: 10024755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An interview with Scott Weingarten, M.D.
    Weingarten S
    Manag Care; 1997 Jul; 6(7):59-62, 67-8. PubMed ID: 10169984
    [No Abstract]   [Full Text] [Related]  

  • 11. Matters of the heart. Life-saving drugs for cardiac disease are still underused.
    Paul KJ
    Contemp Longterm Care; 1999 Jun; 22(6):53. PubMed ID: 10538230
    [No Abstract]   [Full Text] [Related]  

  • 12. Quality of heart failure care in managed Medicare and Medicaid patients in North Carolina.
    Bertoni AG; Duren-Winfield V; Ambrosius WT; McArdle J; Sueta CA; Massing MW; Peacock S; Davis J; Croft JB; Goff DC
    Am J Cardiol; 2004 Mar; 93(6):714-8. PubMed ID: 15019875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines spread, but how much impact will they have?
    Stevens C
    Med Econ; 1993 Jul; 70(13):66-70, 72-6, 82-4 passim. PubMed ID: 10127087
    [No Abstract]   [Full Text] [Related]  

  • 14. Enhancing the quality of care for patients with coronary heart disease: the design and baseline results of the hastening the effective application of research through technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Parker DG; Cohen SJ
    Am J Manag Care; 2002 Dec; 8(12):1069-78. PubMed ID: 12500883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shortening the time between availability of new medical information and its adoption in general practice.
    Mazonson P; Zagari M; Freston JW
    Med Interface; 1996 Mar; 9(3):71-7. PubMed ID: 10156016
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of valsartan for the treatment of heart-failure patients not receiving ACE inhibitors: a budget impact analysis.
    Smith DG; Cerulli A; Frech FH
    Clin Ther; 2005 Jun; 27(6):951-9. PubMed ID: 16117995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart failure: do we deliver quality care?
    Jain MK; Butler J; Mirvis DM
    Tenn Med; 2003 Feb; 96(2):81-4. PubMed ID: 12645367
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms to improve pharmaceutical use in managed care: to study controls, control the studies.
    Fendrick AM
    Am J Manag Care; 2003 Nov; 9(11):711-2. PubMed ID: 14626468
    [No Abstract]   [Full Text] [Related]  

  • 19. ACE inhibitor use and mortality reduction: do controlled trial results equal clinical practice?
    Schade CP; Hannah KL; Rezek G; Brehm JG
    W V Med J; 2006; 102(1):304-6. PubMed ID: 16706321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of care for secondary prevention for patients with coronary heart disease: results of the Hastening the Effective Application of Research through Technology (HEART) trial.
    Goff DC; Gu L; Cantley LK; Sheedy DJ; Cohen SJ
    Am Heart J; 2003 Dec; 146(6):1045-51. PubMed ID: 14660997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.